Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hcv Cirrhosis'

Hcv Cirrhosis published presentations and documents on DocSlides.

Diagnosis and Treatment of Hepatitis C in the Homeless Popu

Diagnosis and Treatment of Hepatitis C in the Homeless Popu

  • myesha-ticknor
  • 41 Slides

Dr. Joanna Eveland, MS, MD. Clinical Chief for Sp...

Telaprevir in Treatment

Telaprevir in Treatment

  • liane-varnes
  • 6 Slides

Naïve GT-1. ILLUMINATE (Study 111). Phase . 3. T...

Liver Disease in Canada:

Liver Disease in Canada:

  • luanne-stotts
  • 58 Slides

A Crisis in the Making. An Assessment of Liver Di...

Peginterferon alfa-2a (

Peginterferon alfa-2a (

  • tatyana-admore
  • 46 Slides

Pegasys. ). Prepared by: David Spach, MD & H....

Hepatitis B Case Studies

Hepatitis B Case Studies

  • alida-meadow
  • 26 Slides

Nina Kim, MD MSc. Associate Professor of Medicine...

Dore G. J

Dore G. J

  • myesha-ticknor
  • 9 Slides

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

Terry D. Box, MD

Terry D. Box, MD

  • alexa-scheidler
  • 35 Slides

Associate Professor of Medicine. Division of . Ga...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

  • pamella-moone
  • 9 Slides

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Optimal Timing of Hepatitis C Treatment for Patients on the

Optimal Timing of Hepatitis C Treatment for Patients on the

  • phoebe-click
  • 22 Slides

Jagpreet Chhatwal. , . PhD,. 1,2. Sumeyye Samur,...

Sofosbuvir in HCV-

Sofosbuvir in HCV-

  • mitsue-stanley
  • 7 Slides

HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

  • lois-ondreau
  • 21 Slides

3. Rd. International . HIV/Hepatitis . Coinfecti...

Arthur Y. Kim, MD

Arthur Y. Kim, MD

  • stefany-barnette
  • 29 Slides

Assistant Professor of Medicine. Harvard Medical ...

Real World Data

Real World Data

  • kittie-lecroy
  • 76 Slides

REAL-WORLD SAFETY AND EFFECTIVENESS OF OMBITASVIR...

Ombitasvir-Paritaprevir

Ombitasvir-Paritaprevir

  • tatiana-dople
  • 9 Slides

-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...

SAPPHIRE-I

SAPPHIRE-I

  • ellena-manuel
  • 8 Slides

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir

Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir

  • pamella-moone
  • 12 Slides

SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...

Elbasvir

Elbasvir

  • pamella-moone
  • 7 Slides

+ . Grazoprevir. in . GT 1 . and Chronic Renal ...

No randomisation

No randomisation

  • pamella-moone
  • 6 Slides

Open-label. 18-70 years. HCV genotype 1. Naïve o...

. HEPATITIS

. HEPATITIS

  • alexa-scheidler
  • 36 Slides

HEPATITIS. Hepatitis. -Is inflammation of the liv...

3 D (Paritaprevir-Ritonavir-Ombitasvir

3 D (Paritaprevir-Ritonavir-Ombitasvir

  • aaron
  • 7 Slides

. + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase...

U niversity of Florida

U niversity of Florida

  • pamella-moone
  • 35 Slides

Bloodborne. . Pathogen Training. Biological Safe...

No randomisation

No randomisation

  • tatiana-dople
  • 6 Slides

N = 100. W12. W24. Arm B: . compensated cirrhosis...

Chapter 61

Chapter 61

  • cheryl-pisano
  • 41 Slides

Care of Patients with Liver Problems. Mrs. Kreise...

Access to antiviral drugs for treating HCV for HIV-positive

Access to antiviral drugs for treating HCV for HIV-positive

  • yoshiko-marsland
  • 12 Slides

AIDS 2016 | 18-22 July 2016 | Durban, South A...

SMV 150 mg

SMV 150 mg

  • faustina-dinatale
  • 5 Slides

qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....

Ledipasvir-Sofosbuvir (

Ledipasvir-Sofosbuvir (

  • lindy-dunigan
  • 127 Slides

Harvoni. ). Prepared by: . David H. Spach, MD and...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

  • mitsue-stanley
  • 15 Slides

With Or Without Ribavirin Is Safe and Efficacious...

Outpatient Morning Report

Outpatient Morning Report

  • liane-varnes
  • 40 Slides

7/28/14. Porter Glover, MD. ELEVATED LFTs. Outpat...

CF Liver Disease and the Role of Transplantation

CF Liver Disease and the Role of Transplantation

  • trish-goza
  • 57 Slides

Jon . Bishop. Consultant Paediatric Gastroenterol...

Boceprevir

Boceprevir

  • aaron
  • 7 Slides

with PEG + RBV in Genotype 1. SPRINT. -1. Phase ....

Boceprevir in Treatment Naive

Boceprevir in Treatment Naive

  • min-jolicoeur
  • 7 Slides

SPRINT-2. Phase 3, Treatment . Naive. Treatment. ...

Non-Invasive Testing for Liver Fibrosis

Non-Invasive Testing for Liver Fibrosis

  • celsa-spraggs
  • 20 Slides

John Scott, MD, MSc. Associate Professor, Univers...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

  • giovanna-bartolotta
  • 9 Slides

VALENCE Trial. Phase . 3. Treatment. Naïve and ...

Single arm

Single arm

  • min-jolicoeur
  • 4 Slides

Open label. ≥ . 18 years, . HCV genotype 1 to ...

Estimates of People with Hepatitis C in Indiana

Estimates of People with Hepatitis C in Indiana

  • cheryl-pisano
  • 4 Slides

Number People with Reactive anti-HCV Antibody. Un...

OBV/PTV/r

OBV/PTV/r

  • conchita-marotz
  • 5 Slides

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

PRIMARY HEPATOCELLULAR CARCINOMA RESEARCH IN ZIMBABWE AND C

PRIMARY HEPATOCELLULAR CARCINOMA RESEARCH IN ZIMBABWE AND C

  • test
  • 20 Slides

Hilda T Marima- Matarira. Professor of Chemical P...

Gynecomastia

Gynecomastia

  • pamella-moone
  • 45 Slides

. Dr. . Ayed. . Alanezi. Senior . spescialist....

ION-4

ION-4

  • briana-ranney
  • 8 Slides

Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...

C-SWIFT Study: elbasvir/grazoprevir + SOF

C-SWIFT Study: elbasvir/grazoprevir + SOF

  • pamella-moone
  • 10 Slides

in genotypes 1 or 3, with or without cirrhosis. &...

Copyright © 2024 DocSlides. All Rights Reserved